Irubis wants to automate the process development and manufacture of biopharmaceutical drugs
Irubis has raised €2.8M across 1 funding round from 6 investors, most recently a round in Oct 2022. Based in Munich, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-10-06 | Other | €2.8M |
| Angel Investors,EIC Fund,High-Tech Gründerfonds (HTGF),Initiative for Industrial Innovators,Ventura BioMed,Verve Ventures |
| View deal → |
